IDYA
Price
$22.18
Change
-$0.10 (-0.45%)
Updated
Jun 13 closing price
Capitalization
1.94B
59 days until earnings call
INBX
Price
$14.57
Change
+$0.24 (+1.67%)
Updated
Jun 13 closing price
Capitalization
210.91M
66 days until earnings call
Interact to see
Advertisement

IDYA vs INBX

Header iconIDYA vs INBX Comparison
Open Charts IDYA vs INBXBanner chart's image
IDEAYA Biosciences
Price$22.18
Change-$0.10 (-0.45%)
Volume$862.85K
Capitalization1.94B
Inhibrx Biosciences
Price$14.57
Change+$0.24 (+1.67%)
Volume$52.26K
Capitalization210.91M
IDYA vs INBX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. INBX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and INBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (IDYA: $22.18 vs. INBX: $14.57)
Brand notoriety: IDYA and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 61% vs. INBX: 57%
Market capitalization -- IDYA: $1.94B vs. INBX: $210.91M
IDYA [@Biotechnology] is valued at $1.94B. INBX’s [@Biotechnology] market capitalization is $210.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 6 TA indicator(s) are bullish while INBX’s TA Score has 6 bullish TA indicator(s).

  • IDYA’s TA Score: 6 bullish, 4 bearish.
  • INBX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both IDYA and INBX are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а +2.07% price change this week, while INBX (@Biotechnology) price change was +4.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.94B) has a higher market cap than INBX($211M). INBX YTD gains are higher at: -5.390 vs. IDYA (-13.696). INBX has higher annual earnings (EBITDA): 1.73B vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. INBX (217M). IDYA has less debt than INBX: IDYA (26M) vs INBX (107M). IDYA has higher revenues than INBX: IDYA (7M) vs INBX (200K).
IDYAINBXIDYA / INBX
Capitalization1.94B211M921%
EBITDA-356.46M1.73B-21%
Gain YTD-13.696-5.390254%
P/E RatioN/A0.12-
Revenue7M200K3,500%
Total Cash693M217M319%
Total Debt26M107M24%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAINBX
RSI
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 24 days ago
77%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAIEX9.800.10
+1.03%
Spirit of America Energy Institutional
GCSLX20.89N/A
N/A
Victory Pioneer Global Equity C
HLPPX10.01N/A
N/A
LDR Real Estate Value Opportunity P
JEPIX13.91-0.11
-0.78%
JPMorgan Equity Premium Income I
TSMNX14.52-0.24
-1.63%
Nuveen Quant Small/Mid Cap Eq I

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.45%
IMNM - IDYA
60%
Loosely correlated
-6.03%
CGON - IDYA
60%
Loosely correlated
-2.42%
CRNX - IDYA
56%
Loosely correlated
-1.24%
XENE - IDYA
56%
Loosely correlated
-0.12%
DNLI - IDYA
55%
Loosely correlated
-2.51%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with IMNM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+1.67%
IMNM - INBX
41%
Loosely correlated
-6.03%
ACET - INBX
38%
Loosely correlated
-3.80%
GBIO - INBX
37%
Loosely correlated
-3.63%
INVA - INBX
37%
Loosely correlated
+1.36%
COGT - INBX
37%
Loosely correlated
-1.94%
More